AHA 2008 schedule

Here is the page we will use to coordinate interviews at AHA 2008

Filming location: 1001 S. Peters Street, New Orleans, Louisiana, USA 70130

Click on Date for Detailed Schedule
Friday November 7, 2008

Saturday November 8, 2008

Sunday November 9, 2008

Monday November 10, 2008

Tuesday November 11, 2008

Wednesday November 12, 2008

8:00 AM
8:00 AM - 4:00 PM
 * SP Corp Global CV Summit
 * Location: InterContinental Hotel

2:15 PM CMG presents "Minimizing the risk of bleeding will have the greatest impact on outcomes in patients with atherothrombosis"

8:00 AM
8:00 AM - 5:00 PM
 * INTENSIVE Steering Committee Meeting
 * Location: Windsor Court Hotel

8:30 AM - 9:30 AM CMG presents

Return to top

4:00 PM
4:00 PM - 6:00 PM
 * Meeting

7:00 PM
7:00 PM - 10:00 PM
 * Event: 24th Annual Symposium on Interventional and Pharm. Reperfusion of STEMI
 * Location: New Orleans Marriott at the Convention Center - Blaine Kern Ballroom C - 1st Floor (859 Conv. Center Blvd.)

8:35 PM - 8:55 PM CMG presents "Antiplatelet Therapy in AMI: Data from TIMI 38"

7:00 PM

 * Event: TIMI Study Group 25th Anniversary Dinner
 * Location: Loews New Orleans- 300 Poydras Street

Return to top

8:00 AM

 * Breakfast meeting

9:30 AM

 * Film Mike

11:30 AM
11:30 AM - 12:00 PM
 * Event: Taping- Best of Scientific Sessions 2008
 * Location: meeting Room R02

12:00 PM
12:00 PM - 1:00 PM
 * Event: Videotape with the AHA re: ATLAS presentation
 * Location: Hall H

1:30 PM

 * Interviewee: Franck Paganelli (on behalf of Laurent Bonello)
 * Confirmed (Y/N): Y
 * Trial: Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent stent thrombosis
 * Slides (Y/N): Y
 * Phone number: 33 6 03456944 (cell)

2:00 PM

 * Interviewee: Dr. Chris Granger and Mayme Lou Roettig
 * Confirmed (Y/N): Y
 * Topic: AHA's Mission: Lifeline
 * Slides (Y/N):
 * Phone number: 704-975-1629 (Mayme cell)

2:30 PM

 * Interviewee: Rino Sardella
 * Confirmed (Y/N): Y
 * Topic: Impact of Thromboaspiration during Primary PCI on Infarcted Segmental Myocardial Function: A Tissue Doppler Imaging Evaluation.EXPIRA Trial Substudy
 * Slides (Y/N):
 * Phone number: 011 +393356572872 (cell)

3:00 PM

 * Interviewee: Kathryn E. Flynn and Ileana Pina
 * Confirmed (Y/N): Y
 * Trial: Effect of Exercise Training on Health-related Quality of Life in Patients with Chronic Heart Failure: An HF-ACTION Substudy
 * Slides (Y/N):
 * Phone number: 919-740-3891 (Kathryn cell)

3:00 PM
3:00 PM - 4:30 PM
 * Lauren's poster (Board Number: C120)

3:30 PM

 * Interviewee: Stefan Anker
 * Confirmed (Y/N): Y
 * Trial: Mid-Regional pro-Adrenomedullin (proADM) vs BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial
 * Slides (Y/N):
 * Phone number: +49-177-4590950 (cell)

4:30 PM

 * Interviewee: Barry Massie
 * Confirmed (Y/N): Y
 * Trial: The I-PRESERVE Trial: A Randomized Double-Blind Placebo-Controlled Trial of Irbesartan in the Treatment of Heart Failure in Patients with Preserved Ejection Fraction
 * Slides (Y/N):
 * Phone number: 415-637-5317 (cell)

7:00 PM
7:00 PM - 10:00 PM
 * Event: ATLAS Investigator Dinner
 * Location: Loews New Orleans- 300 Poydras Stree, Louisiana Ballroom (1 or 2)

Return to top

6:15 AM

 * Breakfast meeting

8:00 AM
8:00 AM - 9:30 AM
 * Event: Late-Breaking Clinical Trials II News conference
 * Location: News Media Center, Hall J

9:00 AM

 * Yuri's talk in Auditorium C

10:45 AM

 * Event: CMG's Late Breaking Clinical Trial presentation- Randomized Comparison of Rivaroxaban, an Oral Direct Factor Xa Inhibitor, with Placebo in Patients with Acute Coronary Syndromes: The ATLAS ACS-TIMI 46 Trial
 * Location: Hall F

1:00 PM
1:00 PM - 3:00 PM
 * Event: ATLAS 2 Investigator Meeting
 * Location: Loews New Orleans - 300 Poydras Street, Louisiana Ballroom (1 or 2)

2:00 PM
2:30 PM - 4:30 PM
 * Event: Advisory Committee Meeting
 * Location: Westin New Orleans Canal Place- Imperial Room (100 Rue Iberville)

5:00 PM

 * Meeting

7:00 PM
7:00 PM - 10:00 PM
 * Event: Symposium: "The ACC/AHA 2007 Guidelines: A Town Hall Meeting Reviewing the Controversies Surrounding Antiplatelet and Antithrombotic Agents"
 * Location: JW Marriott New Orleans - Ile de France 1&2 (614 Canal Street)

Return to top

7:30 AM

 * Breakfast meeting

9:00 AM

 * Interviewee: Dr. Nissen
 * Confirmed (Y/N): Y
 * Topics: 1) Vulnerable plaque hype-othesis, 2) Utility of IVUS or IMT in clincal trials validation of other imaging techniques, 3) Role of biomarkers in clinical investigation, 4) Interpreting JUPITER
 * Slides (Y/N):
 * Phone number:

9:30 AM

 * Interviewee: Matthias Friedrich
 * Confirmed (Y/N): Y
 * Topic: Use of cMRI in practice, what this adds to clinical information, the role of the cardiologist in cMRI
 * Slides (Y/N):
 * Phone number: 403-607-5545 (cell)

10:00 AM

 * Interviewee: Jane Armitage
 * Confirmed (Y/N): Y
 * Trial: SEARCH (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine): randomized comparison of folic acid 2mg plus vitamin B12 1mg daily versus placebo for 7 years in 12,064 myocardial infarction survivors
 * Slides (Y/N):
 * Phone number: +447818 030805 (cell)

10:30 AM

 * Interviewee: Joanne Foody
 * Confirmed (Y/N): Y
 * Topic: Connecting inflammation and abdominal obesity
 * Slides (Y/N):
 * Phone number:

11:00 AM

 * Interviewee: Laura Mauri
 * Confirmed (Y/N): Y
 * Trial: Drug-Eluting and Bare Metal Stenting in Patients with Diabetes Mellitus: Results from the Mass-DAC Registry
 * Slides (Y/N):
 * Phone number: 617-791-5830 (cell)

11:30 AM

 * Interviewee: Hisao Ogawa
 * Confirmed (Y/N): Y
 * Trial: Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes trial (JPAD trial)
 * Slides (Y/N):
 * Phone number: +81-90-7981-4618 (cell)

12:00 PM

 * Meeting with Bill Lis

1:15 PM

 * Interviewee: Michael Davidson
 * Confirmed (Y/N): Y
 * Topics: 1) pre diabetes, 2) what serum glucose triggers next steps with diet/education, 3) OGTT role, 4) inflammation, 5) weight/BMI/waist to hip ratio
 * Slides (Y/N):
 * Phone number: 312-401-6141 (cell)

2:00 PM

 * Interviewee: Lori Mosca
 * Confirmed (Y/N): Y
 * Trial: A Novel Family-based Intervention Trial to Improve Heart Health (FIT Heart): Results of a Randomized Controlled Trial
 * Slides (Y/N):
 * Phone number: 201-336-4729 (cell)

2:30 PM

 * Interviewee: Heinz Peter Schultheiss
 * Confirmed (Y/N): Y
 * Trial: The effect of subcutaneous treatment with interferon-beta-1b over 24 weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy
 * Slides (Y/N):
 * Phone number: 0173-261 75 73 (cell)

3:30 PM

 * Interviewee: Stephen Nicholls
 * Confirmed (Y/N): Y
 * Topic: Novel targets/pathways for inflammation
 * Slides (Y/N):
 * Phone number:

4:30 PM

 * Interviewee: Samuel Goldhaber
 * Confirmed (Y/N): Y
 * Topic: Pulmonary embolism
 * Slides (Y/N):
 * Phone number: 617-966-2719 (cell)

5:00 PM

 * Interviewee: Paul Gurbel
 * Confirmed (Y/N): Y
 * Topics: prt128 abstract
 * Slides (Y/N):
 * Phone number:

5:30 PM

 * Interviewee: Sanjay Kaul
 * Confirmed (Y/N): Y
 * Topics: 1. Prasugrel 2. JUPITER 3. SYNTAX 4. PCI vs medical therapy for stable angina
 * Slides (Y/N):
 * Phone number:

6:00 PM

 * Interviewee: William Weintraub
 * Confirmed (Y/N): Y
 * Topics:
 * Slides (Y/N):
 * Phone number:

7:00 PM

 * Dinner Meeting

Return to top

11:20 AM

 * Yuri's moderated e-poster in Halls A1-A2

6:00 PM
Return to top

INTERVIEW IDEAS FOR WIKIDOC AHA
Business/General:

·       Pfizer drops CV research:  Pfizer exec

·       DeCode situation:

·       A Systematic Approach to Cost Savings in the Cath Lab:  Dick Kessler (VHA exec)

·       How Does the Election Affect Stem Cell Research?

·       How Does the Election Affect Biotech/Pharma Development?

·       Universal Health Care?

·       Transition from Fellow to Faculty:  Prospero Gogo (U Vermont)

·       Future of ACC:  Ralph Brindis

·       Women in Cardiology:  Cindy Grines

·       Interview with Donna Shalala:  Changing the Face of Healthcare in Miami

·       CV Nursing Update:  Denise Busman

·       Critical Care Pharmcy Update:  Gordon Vanscoy

·       Globalization of Clinical Research:  John Alexander

·       Growing Role of Post Marketing Studies:  Rob Calif

·       Transition from Fellowship to Private Practice:  Bart Dawson

·       Developing Technology to Assess CV Risk:  Ray Tabibiazar

·       How many journals can the field support? Calif/Topol

·       Conflict of Interest:  Too Much or Not Enough? John Alexander

·       Pharma sales rep reductions:  What does this mean? Topol

Science/Clinical:

·       Genomics update:  Topol

·       JUPITER:  Ridker

·       Review ISAR studies:  Berger

·       GPIIb/IIIa studies- a year in review:  Valgimigli

·       ACTION REGISTRY update:  Eric Peterson

·       Targeting 5-LO Inhibition:  Tardif

·       Antithrombins under investigation:  Harrington

·       Biomarkers, new assays:  Stan Hazen

·       BEACON registry update:  Venu Menon

·       AZD6140 update:  Moliterno

·       IMPROVE IT update:  Calif

·       Stem Cell Update:  Doris Taylor

·       Anything new in Cardiogenic Shock:  Judy Hochman

·       Pulmonary Embolism and PAD Call to Action:  Sam Goldhaber

·       Bridging to Surgery with GPIIb/IIIa:  Sanjay Kaul

·       LVADs:  Kirk Garratt? Howard Cohen?

·       FDG-PET update:  Zahi Fayad

·       Universal Definition of MI:  Are we using this?:  Harrington

·       Enrolling Women in Clinical Trials:  Sharonne Hayes

·       Endocannabinoid Pathway Drug Development:

·       What Does Coronary Calcium Tell Me?

·       Managing acute stroke in the cath lab

·       TIMACS:  Shamir Mehta

·       Heart Failure and Exercise: Chris O’Connor